Paper
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
Cite this as:
BMJ
2002;325:1202
Related articles
Published 13 June 2012; BMJ 344 doi: 10.1136/bmj.e3533
Published 9 January 2009; BMJ 338 doi: 10.1136/bmj.a3083
Analysis and Comment: Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence
Published 23 November 2006; BMJ 333 doi: 10.1136/bmj.39000.486701.68
Editorial: The polypill and cardiovascular disease
Published 5 May 2005; BMJ 330 doi: 10.1136/bmj.330.7499.1035
Published 10 May 2003; BMJ 326 doi: 10.1136/bmj.326.7397.1035/a
This Week In the BMJ: High homocysteine causes cardiovascular disease
Published 23 November 2002; BMJ 325 doi: 10.1136/bmj.325.7374.0/a
Data supplement
Published
See more
Published 16 May 2013; BMJ 346 doi: 10.1136/bmj.f3215
Published 16 May 2013; BMJ 346 doi: 10.1136/bmj.f3205
Published 15 May 2013; BMJ 346 doi: 10.1136/bmj.f3155
Research News: No cardiovascular benefit from fish oil for high risk adults
Published 15 May 2013; BMJ 346 doi: 10.1136/bmj.f3086
Published 15 May 2013; BMJ 346 doi: 10.1136/bmj.f3087
This article has been cited by other articles:








Social bookmarking